Tratamiento de la distonia focal con toxina botulinica / Treatment of focal dystonia with botulinic toxin
Rev. méd. Panamá
;
21(3): 121-131, Sept. 1996.
Artículo
en Español
| LILACS
| ID: lil-409865
ABSTRACT
Dystonia is a neurologic disease characterized by involuntary repetitive muscular contractions which frequently causes torsion, spasmodic movements or abnormal postures. Pharmacologic and surgical treatment had been unsatisfactory in the majority of the cases. Intramuscular botulinic toxin application in focal dystonia disorders, achieve relief in approximately 90% of the cases by quimiodenervation. We included 35 patients with focal dystonia treated between November 1994 through June 1996 14 facial hemispasm, nine blepharospasm, five cervical dystonia, two writer's cramps, one oromandibular dystonia and four patients with mixed focal dystonia. Improvement between 50-90% was observed in 32/34 (94%) of the patients; one case (2.8%) with therapeutic failure and one case (2.8%) never returned to quantify the response. Actually, botulinic toxin is the first choice treatment of focal dystonia and other diseases related to involuntary muscle spasm
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Toxinas Botulínicas
/
Distonía
Tipo de estudio:
Estudio observacional
Límite:
Adolescente
/
Adulto
/
Femenino
/
Humanos
/
Masculino
Idioma:
Español
Revista:
Rev. méd. Panamá
Asunto de la revista:
Medicina
Año:
1996
Tipo del documento:
Artículo
País de afiliación:
Panamá
Similares
MEDLINE
...
LILACS
LIS